Menu
Currency
GWAS Study

Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci.

Ortiz-Fernández L, Carmona FD, Montes-Cano MA et al.

27548383 PubMed ID
GWAS Study Type
2530 Participants
56 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

OL
Ortiz-Fernández L
CF
Carmona FD
MM
Montes-Cano MA
GJ
García-Lozano JR
CM
Conde-Jaldón M
ON
Ortego-Centeno N
CM
Castillo MJ
EG
Espinosa G
GG
Graña-Gil G
SJ
Sánchez-Bursón J
JM
Juliá MR
SR
Solans R
BR
Blanco R
BA
Barnosi-Marín AC
GD
Gómez de la Torre R
FP
Fanlo P
RM
Rodríguez-Carballeira M
RL
Rodríguez-Rodríguez L
CT
Camps T
CS
Castañeda S
AJ
Alegre-Sancho JJ
MJ
Martín J
GM
González-Escribano MF
Chapter II

Abstract

Summary of the research findings

Behcet's disease (BD) is an immuno-mediated vasculitis in which knowledge of its etiology and genetic basis is limited. To improve the current knowledge, a genetic analysis performed with the Immunochip platform was carried out in a population from Spain. A discovery cohort comprising 278 BD cases and 1,517 unaffected controls were genotyped using the Immunochip platform. The validation step was performed on an independent replication cohort composed of 130 BD cases and 600 additional controls. The strongest association signals were observed in the HLA class I region, being HLA-B*51 the highest peak (overall P = 6.82E-32, OR = 3.82). A step-wise conditional logistic regression with classical alleles identified HLA-B*57 and HLA-A*03 as additional independent markers. The amino acid model that best explained the association, includes the position 97 of the HLA-B molecule and the position 66 of the HLA-A. Among the non-HLA loci, the most significant in the discovery analysis were: IL23R (rs10889664: P = 3.81E-12, OR = 2.00), the JRKL/CNTN5 region (rs2848479: P = 5.00E-08, OR = 1.68) and IL12A (rs1874886: P = 6.67E-08, OR = 1.72), which were confirmed in the validation phase (JRKL/CNTN5 rs2848479: P = 3.29E-10, OR = 1.66; IL12A rs1874886: P = 1.62E-08, OR = 1.61). Our results confirm HLA-B*51 as a primary-association marker in predisposition to BD and suggest additional independent signals within the class I region, specifically in the genes HLA-A and HLA-B. Regarding the non-HLA genes, in addition to IL-23R, previously reported in our population; IL12A, described in other populations, was found to be a BD susceptibility factor also in Spaniards; finally, a new associated locus was found in the JRKL/CNTN5 region.

278 Spanish ancestry cases, 1,517 Spanish ancestry controls

Chapter III

Study Statistics

Key metrics and study information

2530
Total Participants
GWAS
Study Type
Yes
Replicated
up to 130 Spanish ancestry cases, up to 605 Spanish ancestry controls
Replication Participants
European
Ancestry
Spain
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.